Genomics One Corporation announces the sale of its BioCan Scientific Inc. subsidiaries to Medicorp Inc.
Genomics One Corporation announced that its Board of Directors has approved the terms of a Sale Transaction between Genomics One and Medicorp Inc. of Montreal for the sale of the assets of its BioCan Scientific subsidiaries in Canada and in the US. The Asset Sale Agreement contemplates purchase of all of the trade related assets of BioCan Scientific by Medicorp Inc. The Sale Transaction has a total estimated value of $677,330, all payable in cash.
The closing of the Sale Transaction is planned for May 31st, 2005 at which time Medicorp Inc. will pay $500,000, with the balance of $177,330 being held in escrow for 90 days. The escrow amount, with accumulated interest, will be paid to the sellers, after customary trade adjustments, if any, to be agreed between the parties. The Sale Transaction requires the approval of a majority of the Shareholders of Genomics One. Two major shareholders, and co-founders, of Genomics One with total holdings representing 49.18% and 9 other shareholders representing 1.45%, for a total of 50.63% of the outstanding shares of Genomics One, are approving the Sale Transaction.
The market for research reagents and components is a very competitive market and over the past years Genomics One Corporation has been working on new business opportunities. As previously announced, the Corporation has decided to enter into the BioDefense market with innovative Mass Spectrometry Technology. The Corporation will now focus all of its efforts and resources on this significant market opportunity. Successful conclusion of this transaction will enable Genomics One to focus on and execute its new strategic plan in the BioDefense market while at the same time pursuing its related equity financing activities.
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
